Agragene

Overview
News
Biopesticides?
Product stageSegments
Minimum Viable Product
?
Biotic agents
?

Agragene is an agricultural biotechnology company specializing in sustainable pest control solutions. It has developed a proprietary technology called Precision Guided Sterile Insect Technology that leverages CRISPR gene-editing to sterilize male insects. These sterile male insects are then released into crop fields to mate with female pests, preventing offspring from being produced and controlling the pest population without the use of chemical pesticides. Initially, Agragene targeted its technology toward the spotted wing drosophila, an invasive fruit fly species that causes significant damage to fruit crops worldwide.

Originally founded in 2017 and based in San Diego, California, Agragene faced challenges in meeting its development timeline and high operational costs. In April 2022, the company relocated its headquarters to St. Louis, Missouri, capitalizing on the region's talent pool in agriculture and proximity to other agtech companies. Since the relocation, Agragene has expanded its team, added new employees, and raised USD 2 million in financing led by BioGenerator in 2023. The move has also reduced Agragene's burn rate, the pace at which it spends its funding, by two-thirds compared to its operations in San Diego.

Agragene continues to advance its research and development efforts, collaborating with the US Department of Agriculture to build a data case for commercialization. The company was preparing for open field testing of its technology, pending the necessary regulatory permits.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
9620 Towne Centre Drive 100 San Diego CA USA
Founded year:
2017
Employees:
1-10
IPO status:
Private
Total funding:
USD 5.2 mn
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.